EPS Revisions Fuel Double-Digit Gains: QNRX +47%, NTSK +29%, NMAX +24%
Today's top performers were led by QNRX, which surged 47.1% after its EPS growth estimate was raised from 45.4% to 54.8%. NTSK gained 29.2% as analysts boosted its forward EPS estimate to 112.0%, while NMAX rose 23.8% on a massive revision from 159.1% to 376.9%. Each move was detected by our EPS revision screener and confirmed by subsequent price action, with some stocks benefiting from additional news catalysts.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| QNRX | Healthcare | 2026-06-23 | +9.5pp | +47.1% |
| NTSK | Technology | 2026-06-22 | N/A | +29.2% |
| NMAX | Communication Services | 2026-06-28 | +217.8pp | +23.8% |
| BILL | Technology | 2026-06-22 | N/A | +22.5% |
| APP | Communication Services | 2026-06-23 | N/A | +21.8% |
Why did QNRX stock jump in July 2026?
QNRX jumped 47.1% (from $3.25 to $4.78) after analysts raised its forward EPS growth estimate from 45.4% to 54.8% on June 23.
The revision was detected by the screener on that date, and the stock has continued to climb as the market priced in the improved outlook. No additional news accompanied the move, suggesting the revision itself was the primary catalyst. As a small-cap healthcare name, QNRX may have attracted momentum traders following the estimate upgrade.
QNRX EPS revision history → · Screener snapshot from 2026-06-23 →
FAQ: QNRX
Why did QNRX stock jump in June 2026?
QNRX jumped 47.1% after analysts raised its forward EPS growth estimate from 45.4% to 54.8% on June 23, with no other news catalysts.
What is QNRX's EPS growth estimate?
QNRX's forward EPS growth estimate was revised from 45.4% to 54.8%, a 9.5 percentage point increase.
Is QNRX a buy after the rally?
QNRX's price gain reflected the estimate revision, but investors should consider the sustainability of the growth outlook given no recent operational news.
Why did NTSK stock jump in July 2026?
NTSK jumped 29.2% (from $8.95 to $11.56) after analysts raised its forward EPS growth estimate to 112.0% on June 22.
The technology sector saw broad strength, but Netskope's specific revision stood out. The screener identified the upward estimate change on June 22, and the stock has since rallied as investors reassessed growth prospects. With no company-specific news, the move appears driven by analyst confidence in future earnings.
NTSK EPS revision history → · Screener snapshot from 2026-06-22 →
FAQ: NTSK
Why did NTSK stock jump in June 2026?
NTSK jumped 29.2% after analysts raised its forward EPS growth estimate to 112.0% on June 22, with no other news catalysts.
What is NTSK's EPS growth estimate?
NTSK's forward EPS growth estimate was raised to 112.0%, indicating strong expected earnings growth.
What caused NTSK's surge?
The surge was driven solely by the upward EPS revision, as the stock rallied without any accompanying company announcements.
Why did NMAX stock jump in July 2026?
NMAX jumped 23.8% (from $7.49 to $9.27) after analysts raised its forward EPS growth estimate from 159.1% to 376.9% on June 28.
The 217.8 percentage point revision is unusually large, signaling a dramatic shift in expectations. Newsmax operates in conservative media, and the upgrade may reflect increased advertising revenue or subscriber growth. The lack of formal news suggests the revision was based on proprietary analysis or sector tailwinds.
NMAX EPS revision history → · Screener snapshot from 2026-06-28 →
FAQ: NMAX
Why did NMAX stock jump in June 2026?
NMAX jumped 23.8% after analysts raised its forward EPS growth estimate from 159.1% to 376.9% on June 28, a massive revision.
Is NMAX a buy after the rally?
NMAX's 23.8% gain reflects the dramatically improved outlook, but investors should validate the assumptions behind the 376.9% growth estimate.
What caused NMAX's surge?
The surge was caused by an extraordinary 217.8 percentage point upward revision to its EPS growth estimate, with no other news.
Why did BILL stock jump in July 2026?
BILL jumped 22.5% (from $31.96 to $39.15) after analysts raised its forward EPS growth estimate to 26.3% on June 22.
The revision was reinforced on June 25 when BILL appointed Jonathan Leaf as Chief Revenue Officer, a move aimed at accelerating growth and elevating customer experience. This news provided additional confidence in the company's ability to execute on its revised estimates. The stock has since climbed further as the market absorbed the positive outlook.
BILL EPS revision history → · Screener snapshot from 2026-06-22 →
FAQ: BILL
Why did BILL stock jump in June 2026?
BILL jumped 22.5% after analysts raised its forward EPS growth estimate to 26.3% on June 22, and the move was reinforced by the appointment of a new Chief Revenue Officer on June 25.
What is BILL's EPS growth estimate?
BILL's forward EPS growth estimate was raised to 26.3%, indicating moderate but improved earnings expectations.
Is BILL a buy after the rally?
BILL's rally was supported by both the EPS revision and a positive management change, but investors should monitor execution against the growth outlook.
Why did APP stock jump in July 2026?
APP jumped 21.8% (from $467.02 to $568.67) after analysts raised its forward EPS growth estimate to 33.7% on June 23.
The revision was followed by a Raymond James initiation with a 'Strong Buy' rating and $640 price target on June 29, citing expansion into e-commerce advertising as a significant growth opportunity. The stock regained its 50-day moving average on that news. APP's upcoming Q2 earnings announcement on July 1 keeps momentum alive.
APP EPS revision history → · Screener snapshot from 2026-06-23 →
FAQ: APP
Why did APP stock jump in June 2026?
APP jumped 21.8% after analysts raised its forward EPS growth estimate to 33.7% on June 23, and subsequent analyst initiation with a 'Strong Buy' on June 29 boosted the stock further.
Is APP a buy after the rally?
APP's rally was driven by EPS revision and a bullish analyst initiation, but the upcoming Q2 earnings report will be key for sustaining momentum.
What caused APP's surge?
The surge was caused by an EPS revision to 33.7% growth and a Raymond James initiation with a $640 target, highlighting e-commerce advertising expansion.
The broad-based rallies across healthcare, technology, and communication services indicate that investors are rewarding companies with improving earnings outlooks. The lack of major macro news suggests stock-specific estimate revisions are currently the primary driver of momentum.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →